Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03176576 · ClinicalTrials.gov registry record · NA

Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population

A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT03176576: Completed NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NCT03176576 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03176576, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

The purpose of this study is to develop and test a model of patient navigation that investigators hope will address the unique needs of adolescent and young adult (AYA) cancer patients and their families by minimizing barriers in their care and potentially improving the outcomes of their treatment while reducing distress and enhancing quality of life. Investigators plan to achieve this by increasing access to, and use of, the resources available at Moffitt Cancer Center for AYA patients and their families.

Primary Outcome

Rate of participants reporting satisfaction with the patient navigator service, based on survey response scores.

Interventions

  • BEHAVIORAL Patient Navigator (PN)
  • OTHER Follow-up Questionnaire
  • OTHER Baseline Questionnaire
  • OTHER Patient Navigator Satisfaction Survey

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2017-06-13
Est. Completion 2021-08-20
Phase NA

What the finished NCT03176576 record still lists

NCT03176576 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 4 interventions - of which Patient Navigator (PN) is the first listed.

NCT03176576 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03176576 about?

NCT03176576 is a clinical study titled "Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population". The purpose of this study is to develop and test a model of patient navigation that investigators hope will address the unique needs of adolescent and young adult (AYA) cancer patients and their families by minimizing barriers in their care and potentially improving the outcomes of their treatment w...

What is the current status of trial NCT03176576?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2017-06-13. Estimated completion is 2021-08-20.

What interventions are being tested in trial NCT03176576?

The interventions under investigation include: Patient Navigator (PN) (BEHAVIORAL), Follow-up Questionnaire (OTHER), Baseline Questionnaire (OTHER), Patient Navigator Satisfaction Survey (OTHER).

Who is sponsoring clinical trial NCT03176576?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03176576's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03176576, the US trial registry maintained by the National Library of Medicine. NCT03176576 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.